MARKET

BMNDF

BMNDF

Biomind Labs Inc
OTCPK
0.055
0.000
0.00%
Closed 09:40 07/24 EDT
OPEN
0.055
PREV CLOSE
0.055
HIGH
0.055
LOW
0.055
VOLUME
148.00K
TURNOVER
8.14K
52 WEEK HIGH
0.198
52 WEEK LOW
0.016
MARKET CAP
4.27M
P/E (TTM)
-4.8246
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BMNDF last week (0713-0717)?
Weekly Report · 6d ago
Weekly Report: what happened at BMNDF last week (0706-0710)?
Weekly Report · 07/13 10:37
Weekly Report: what happened at BMNDF last week (0629-0703)?
Weekly Report · 07/06 10:41
Weekly Report: what happened at BMNDF last week (0622-0626)?
Weekly Report · 06/29 10:35
Weekly Report: what happened at BMNDF last week (0615-0619)?
Weekly Report · 06/22 10:47
Weekly Report: what happened at BMNDF last week (0608-0612)?
Weekly Report · 06/15 10:47
Weekly Report: what happened at BMNDF last week (0601-0605)?
Weekly Report · 06/08 10:41
Weekly Report: what happened at BMNDF last week (0525-0529)?
Weekly Report · 06/01 10:48
More
About BMNDF
Biomind Labs Inc. is a biotechnology research and development company. The Company is focused on transforming biomedical sciences knowledge into novel pharmaceutical drugs and innovative nanotech delivery systems for a variety of psychiatric and neurological conditions. Through its acceleration platform, the Company is developing novel pharmaceutical formulations of the main psychedelic molecules, N, N-dimethyltryptamine (DMT), 5- MeO-DMT, and mescaline (collectively, the Molecules), for treating a wide range of therapeutic indications. DMT is a serotonergic psychedelic that exerts its effects through serotonergic receptors in the brain, including 5-HT2A, 5-HT1A, 5-HT2C and 5-HT7 receptors, among others. Under the 5-MeO-DMT Program, it is focused on two drug candidates: the BMND05: 5-MeO-DMT novel formulation indicated for Chronic Pain and the BMND08: 5-MeO-DMT novel formulation indicated for Alzheimer’s disease. Mescaline is a psychedelic alkaloid of the phenethylamine class.

Webull offers Biomind Labs Inc stock information, including OTCPK: BMNDF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMNDF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMNDF stock methods without spending real money on the virtual paper trading platform.